April 28 (Reuters) - Navamedic ASA NAVA.OL:
NAVAMEDIC ASA: CONCLUSION RECEIVED FROM THE NORWEGIAN FINANCIAL SUPERVISORY AUTHORITY
NFSA HAS CONCLUDED THAT BOND LOAN WAS CREDIT IMPAIRED AS EARLY AS IN 2023
NFSA HAS CONCLUDED THAT COMPANY SHOULD HAVE RECOGNIZED A MATERIAL EXPECTED CREDIT LOSS
LOANS RECEIVABLES AND EQUITY IN BALANCE SHEET WILL BE REDUCED BY ABOUT NOK 17 MILLION IN 2023 AND NOK 7 MILLION IN 2024
Source text: ID:nWkr6NY2rX
Further company coverage: NAVA.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))